Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Bart

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal of Food and Drug Analysis|October 1, 2014
Emerging drug problems in AsiaGavin Bart
Lancet (London, England)|August 23, 2011
Promise of extended-release naltrexone is a red herringGavin Bart
Journal of Addictive Diseases|August 10, 2012
Maintenance medication for opiate addiction: the foundation of recoveryGavin Bart
Molecular Psychiatry|December 22, 2022
When 1 + 1 = 3: the COVID-19 and addiction syndemicGavin Bart
Journal of Ethnicity in Substance Abuse|November 10, 2017
Ethnic differences in psychosocial factors in methadone maintenance: Hmong versus non-HmongGavin Bart
Journal of Addictive Diseases|October 27, 2011
CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?Gavin Bart
Annals of Internal Medicine|August 5, 2009
Concerns about consensus guidelines for QTc interval screening in methadone treatmentGavin Bart
Journal of Food and Drug Analysis|September 23, 2014
Collaborative addiction research in the United States and AsiaGavin Bart
Minnesota Medicine|November 20, 2018
Addressing the opioid epidemic in general medical settingsGavin Bart
Addiction Science & Clinical Practice|August 27, 2019
Commentary on physicians' satisfaction with providing buprenorphine treatment by Knudsen et alGavin Bart, Jeffrey Samet
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Food and Drug Analysis|October 1, 2014
Emerging drug problems in AsiaGavin Bart
Lancet (London, England)|August 23, 2011
Promise of extended-release naltrexone is a red herringGavin Bart
Journal of Addictive Diseases|August 10, 2012
Maintenance medication for opiate addiction: the foundation of recoveryGavin Bart
Molecular Psychiatry|December 22, 2022
When 1 + 1 = 3: the COVID-19 and addiction syndemicGavin Bart
Journal of Ethnicity in Substance Abuse|November 10, 2017
Ethnic differences in psychosocial factors in methadone maintenance: Hmong versus non-HmongGavin Bart
Journal of Addictive Diseases|October 27, 2011
CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?Gavin Bart
Annals of Internal Medicine|August 5, 2009
Concerns about consensus guidelines for QTc interval screening in methadone treatmentGavin Bart
Journal of Food and Drug Analysis|September 23, 2014
Collaborative addiction research in the United States and AsiaGavin Bart
Minnesota Medicine|November 20, 2018
Addressing the opioid epidemic in general medical settingsGavin Bart
Addiction Science & Clinical Practice|August 27, 2019
Commentary on physicians' satisfaction with providing buprenorphine treatment by Knudsen et alGavin Bart, Jeffrey Samet
Pageof 9